Skip to content

Effects of Lipemia and Metformin on Endothelial Function

Effects of Lipemia and Metformin on Endothelial Function

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01037660
Enrollment
139
Registered
2009-12-23
Start date
2005-09-30
Completion date
2016-12-01
Last updated
2017-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

endothelium, cardiovascular disease, dietary fat, insulin resistance

Brief summary

Eating a diet high in fat contributes to the development of atherosclerosis (hardening of the arteries). Acute fat consumption increases levels of fat in the blood and temporarily reduces the ability of blood vessel to dilate (open up to carry additional blood). A similar response is observed during infusion of Intra-Lipid (a fat emulsion used for intravenous nutrition). The present study is designed to help us understand the effects of a fat load on blood vessel function. We will measure arterial dilation using non-invasive techniques before and at the end of a 5-hour infusion of Intra-Lipid in healthy subjects. Subjects will then take the approved drug metformin for two weeks and return for repeat studies of endothelial function with Intra-Lipid infusion. We expect that metformin will help preserve the normal function of blood vessels during a fat load. This study will help us understand how fat affects blood vessels and therefore will advance our knowledge of the development of atherosclerosis and potentially lead to improved methods to prevent and treat heart disease.

Interventions

DRUGMetformin

Metformin 1 gram per day

Sponsors

Boston University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers

Exclusion criteria

* Pregnancy (defined as positive urine pregnancy test) * Diabetes Mellitus (Clinical history or random blood glucose\>140 mg/dl) * Hypertension (Clinical history or SBP\>140 or DBP\>90 mmHg) * History of adverse reaction to metformin * Abnormal renal function (Serum creatinine\>1.4 mg/dl) * Abnormal liver function (AST or ALT greater than two times the upper limit of normal) * Administration of iodinated contrast within 7 days * History of congestive heart failure * Abnormal clotting parameters (INR\>1.5 or PTT\>40 sec) * Anemia (HCT\<30%) * Allergy to soy or egg * Allergy to heparin * The potential subject plans to perform heavy exercise in the setting of low calorie intake during the period of the study such as running or competitive road or bicycle racing

Design outcomes

Primary

MeasureTime frame
Brachial artery flow-mediated dilation6 hours

Secondary

MeasureTime frame
blood lipid levels6 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026